ABT Down 8.5% In A Day. It Dropped More in 2008.
- In Dot-Com Bubble, Abbott Laboratories stock declined 44% vs 37% for S&P 500. During inflation shock, it dropped 36% compared to the S&P 500’s 25%.
- Following the Inflation Shock, the stock has not yet recovered to its pre-crisis peak, whereas the S&P 500 recovered in 15 months. In the global financial crisis, the stock took 35 months to recover, compared to 49 months for the S&P 500.
Abbott Laboratories Stock Performance In Market Crashes:
| ABT | S&P 500 | |
|---|---|---|
| Dot-Com Bubble | ||
| % Change from Pre-Recession Peak | -44% | -37% |
| # of Months for Full Recovery | 9 | 69 |
| Global Financial Crisis | ||
| % Change from Pre-Recession Peak | -31% | -57% |
| # of Months for Full Recovery | 35 | 49 |
| 2018 Correction | ||
| % Change from Pre-Recession Peak | -12% | -20% |
| # of Months for Full Recovery | 2 | 4 |
| Covid Pandemic | ||
| % Change from Pre-Recession Peak | -32% | -34% |
| # of Months for Full Recovery | 1 | 5 |
| Inflation Shock | ||
| % Change from Pre-Recession Peak | -36% | -25% |
| # of Months for Full Recovery | Yet to Recover | 15 |
Worried that ABT is yet to hit the bottom? You could take a look at the Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming the S&P 500 over the last 4-year period. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.
Relevant Articles
- Better Value & Growth: RMD, BDX Lead Abbott Laboratories Stock
- RMD, BDX Top Abbott Laboratories Stock on Price & Potential
- Better Value & Growth: RMD, BDX Lead Abbott Laboratories Stock
- Pay Less, Grow More: RMD, BDX Outshine Abbott Laboratories Stock
- Better Bet Than Abbott Laboratories Stock: Pay Less To Get More From RMD, BDX
- Better Bet Than Abbott Laboratories Stock: Pay Less To Get More From RMD, BDX